HK
BMY icon

Horizon Kinetics’s Bristol-Myers Squibb BMY Stock Holding History

Horizon Kinetics’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2.35M Buy
45,199
+234
+0.5% +$12.6K 0.08% 100
2018
Q3 		$2.79M Sell
44,965
-935
-2% -$55.5K 0.07% 94
2018
Q2 		$2.54M Sell
45,900
-1,215
-3% -$65.6K 0.07% 98
2018
Q1 		$2.98M Sell
47,115
-1,800
-4% -$116K 0.09% 85
2017
Q4 		$3M Sell
48,915
-100
-0.2% -$6.25K 0.09% 91
2017
Q3 		$3.12M Buy
49,015
+25
+0.1% +$1.46K 0.09% 91
2017
Q2 		$2.73M Buy
48,990
+383
+0.8% +$20.8K 0.09% 99
2017
Q1 		$2.64M Sell
48,607
-3,985
-8% -$219K 0.08% 102
2016
Q4 		$3.07M Sell
52,592
-3,732
-7% -$204K 0.1% 90
2016
Q3 		$3.04M Sell
56,324
-2,452
-4% -$158K 0.09% 99
2016
Q2 		$4.32M Sell
58,776
-100
-0.2% -$7.07K 0.11% 82
2016
Q1 		$3.76M Buy
58,876
+1,334
+2% +$84.1K 0.09% 88
2015
Q4 		$3.96M Sell
57,542
-900
-2% -$59.5K 0.09% 91
2015
Q3 		$3.46M Buy
58,442
+2,575
+5% +$163K 0.06% 99
2015
Q2 		$3.72M Sell
55,867
-150
-0.3% -$9.88K 0.05% 113
2015
Q1 		$3.61M Sell
56,017
-6,800
-11% -$426K 0.05% 117
2014
Q4 		$3.71M Sell
62,817
-125
-0.2% -$7.05K 0.05% 124
2014
Q3 		$3.22M Sell
62,942
-30
-0% -$1.5K 0.04% 129
2014
Q2 		$3.05M Buy
62,972
+300
+0.5% +$14.8K 0.04% 132
2014
Q1 		$3.26M Hold
62,672
– – 0.04% 128
2013
Q4 		$3.33M Buy
62,672
+2,100
+3% +$107K 0.04% 127
2013
Q3 		$2.8M Sell
60,572
-838
-1% -$36.8K 0.04% 133
2013
Q2 		$2.74M Buy
+61,410
New +$2.67M 0.04% 137

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Horizon Kinetics's BMY Position: Q4 2018 in Review

Horizon Kinetics increased its Bristol-Myers Squibb (BMY) stake by 0.52% in Q4 2018, buying an estimated $12.6K and bringing the position to 45,199 shares worth $2.35M. The position accounts for 0.08% of the portfolio, ranked #100.

Horizon Kinetics first reported a position in BMY in Q2 2013 and has held it in 23 quarters since. The position peaked at $4.32M in Q2 2016. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

  • Horizon Kinetics held 45,199 shares of Bristol-Myers Squibb worth $2.35M as of Q4 2018.
  • Horizon Kinetics bought 234 Bristol-Myers Squibb shares in Q4 2018, an estimated $12.6K.
  • Bristol-Myers Squibb made up 0.08% of Horizon Kinetics's portfolio in Q4 2018, its #100 holding.
  • Horizon Kinetics first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 23 quarters since.
  • Horizon Kinetics's Bristol-Myers Squibb position peaked at $4.32M in Q2 2016.
  • 1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.